Patients Who Respond to L-DOPA Treatment May Have Dyskinesia Earlier Than Those Who Don’t, Study Finds
People with Parkinson’s disease whose motor symptoms are eased by levodopa (L-DOPA) therapy may be “more likely” to develop earlier in their disease course the abnormal involuntary movements known as dyskinesia than do patients with a limited response to this treatment, researchers report. Data on this finding were presented…